Cargando…
Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a sho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763642/ https://www.ncbi.nlm.nih.gov/pubmed/24281407 http://dx.doi.org/10.3390/ph5040369 |
_version_ | 1782283051403837440 |
---|---|
author | Kubota, Takeo Takae, Hirasawa Miyake, Kunio |
author_facet | Kubota, Takeo Takae, Hirasawa Miyake, Kunio |
author_sort | Kubota, Takeo |
collection | PubMed |
description | The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a short period. Epigenetics is a mechanism that regulates gene expression, depending not on the underlying DNA sequence but on the chemical modifications of DNA and histone proteins. Because mental stress can alter the epigenetic status in neuronal cells, environmental factors may alter brain function through epigenetic changes. However, one advantage of epigenetic changes is their reversibility. Therefore, diseases due to abnormal epigenetic regulation are theoretically treatable. In fact, several drugs for treating mental diseases are known to have restoring effects on aberrant epigenetic statuses, and a novel therapeutic strategy targeting gene has been developed. In this review, we discuss epigenetic mechanisms of congenital and acquired neurodevelopmental disorders, drugs with epigenetic effects, novel therapeutic strategies for epigenetic diseases, and future perspectives in epigenetic medicine. |
format | Online Article Text |
id | pubmed-3763642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-37636422013-11-14 Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders Kubota, Takeo Takae, Hirasawa Miyake, Kunio Pharmaceuticals (Basel) Review The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a short period. Epigenetics is a mechanism that regulates gene expression, depending not on the underlying DNA sequence but on the chemical modifications of DNA and histone proteins. Because mental stress can alter the epigenetic status in neuronal cells, environmental factors may alter brain function through epigenetic changes. However, one advantage of epigenetic changes is their reversibility. Therefore, diseases due to abnormal epigenetic regulation are theoretically treatable. In fact, several drugs for treating mental diseases are known to have restoring effects on aberrant epigenetic statuses, and a novel therapeutic strategy targeting gene has been developed. In this review, we discuss epigenetic mechanisms of congenital and acquired neurodevelopmental disorders, drugs with epigenetic effects, novel therapeutic strategies for epigenetic diseases, and future perspectives in epigenetic medicine. MDPI 2012-04-05 /pmc/articles/PMC3763642/ /pubmed/24281407 http://dx.doi.org/10.3390/ph5040369 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Kubota, Takeo Takae, Hirasawa Miyake, Kunio Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders |
title | Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders |
title_full | Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders |
title_fullStr | Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders |
title_full_unstemmed | Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders |
title_short | Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders |
title_sort | epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763642/ https://www.ncbi.nlm.nih.gov/pubmed/24281407 http://dx.doi.org/10.3390/ph5040369 |
work_keys_str_mv | AT kubotatakeo epigeneticmechanismsandtherapeuticperspectivesforneurodevelopmentaldisorders AT takaehirasawa epigeneticmechanismsandtherapeuticperspectivesforneurodevelopmentaldisorders AT miyakekunio epigeneticmechanismsandtherapeuticperspectivesforneurodevelopmentaldisorders |